WASHINGTON (AP) -- Senators are asking the Justice Department to investigate whether pharmaceutical company Mylan acted illegally when it classified its life-saving EpiPen as a generic drug and qualified for lower rebate payments to states....
By MARY CLARE JALONICK, Associated Press: Health
Wed, 09/28/2016 - 10:36am
WASHINGTON (AP) -- Senators are asking the Justice Department to investigate whether pharmaceutical company Mylan acted illegally when it classified its life-saving EpiPen as a generic drug and qualified for lower rebate payments to states....